Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain

• Published in: Biochimie Vol. 90; no. 3; pp. 426 - 436
• Main Authors: Dutheil, Fabien, Beaune, Philippe, Loriot, Marie-Anne
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.03.2008
• Subjects: Brain - enzymology; Brain - metabolism; Cytochrome P-450 Enzyme System - metabolism; Cytochrome P450 enzymes; Endogenous substrates; Human brain; Humans; Mental Disorders - enzymology; Neurodegenerative diseases; Neurodegenerative Diseases - enzymology; Protein Isoforms - metabolism; Xenobiotics; Xenobiotics - metabolism; Human brain; Cytochrome P450 enzymes; Endogenous substrates; Neurodegenerative diseases; Xenobiotics
• ISSN: 0300-9084; 1638-6183
• DOI: 10.1016/j.biochi.2007.10.007

The metabolism of xenobiotics in human brain constitutes a field of recent intensive research in relation to the potential implications in the pharmacological effect of drugs acting on the central nervous system. Cytochrome P450 enzymes (CYPs) play a crucial role in these metabolic pathways and the existence of functional CYP monooxygenases in brain is now well established. These enzymes are preferentially localized in the neuronal cells within the microsomal fraction and the inner membrane of mitochondria. Although low, the metabolism in situ could influence individual response to xenobiotics or produce reactive, toxic metabolites causing irreversible damage in the neuronal cells. The abundant presence of CYPs in selective cell populations within different regions of the brain has also suggested a role for these enzymes in brain physiology thus not restricted to xenobiotic-induced neurotoxicity. For instance, CYPs participate in the regulation of neurotransmitters and steroids and brain maintenance of cholesterol homeostasis. Recent advances support an additional role for these enzymes in the pathogenesis of psychiatric and neurodegenerative disorders such as depression, schizophrenia, and Alzheimer's and Parkinson's diseases. The characterization of brain CYP isoforms and their localization, the identification of their substrates and metabolic end-products will allow better understanding of the role of these enzymes in brain physiology, development and diseases.